RenalWEB Home Page
Last Updated 06/18/17
 
   
Click for the Membrana web site
   

PubMed Searches

A History of Hemodialysis Adequacy

Maintaining life, but not health

When hemodialysis treatments were first used to replace renal function, no one knew how much dialysis therapy was needed to keep the patients healthy. Doctors knew that they had to maintain the blood levels of certain substances, such as potassium, within a specific range to keep their patients alive. The early pioneers of dialysis quickly mastered the technology to effectively manage these essential tasks. However, after the patients had been on dialysis for a few months, doctors found it was a much bigger challenge to keep these early hemodialysis patients healthy in the long run.

Long term survival on hemodialysis machines became possible in the 1960's.

Many of these early hemodialysis patients had frequent and devastating complications, such as severe infections and inflammation of the heart cavity (pericarditis). Doctors discovered they could reduce or eliminate these complications by dialyzing the patients longer.  Somewhat reluctantly, patients accepted these longer dialysis times as necessary for maintaining their long-term health.  Nephrologists, trying to shorten the 8-10 hour dialysis sessions and also to prevent patients from being under-dialyzed, began looking for an easy-to-measure value (or "marker") to help them determine when a patient was receiving an adequate amount of dialysis therapy.

Urea (or BUN) levels

Urea levels in the blood had long been used to assess kidney function. Patients were typically described as "uremic" when they had renal disease. Urea is a waste product that results from the protein that we eat, digest, and catabolize and is normally excreted in the urine. When doctors saw new patients with renal disease, they observed that the higher the patient's BUN level was, the more ill they were.

BUN stands for Blood Urea Nitrogen.  With normal kidney function, a person has a BUN in the range of 8 - 25 mg/dl.

In those early days, the general consensus was that high levels of urea had a toxic effect. Therefore, many doctors thought that keeping the BUN levels as low as possible would be best for the patients. They knew that the more protein the patients ate, the higher their BUN levels were. Accordingly, many of the early dialysis patients were advised to strictly limit the amount of protein in their diets.

Sad, but true - 1970's Renal Dietary Counseling:
Stop eating so much protein OR WE'LL HAVE TO INCREASE YOUR DIALYSIS TIME !!

When should we measure BUN?

Urea is efficiently removed from the blood by dialysis. It is a small molecule that passes easily through the dialyzer membrane. It is also constantly produced by the body. As you can see, BUN values vary widely over the week. For a Mon/Wed/Fri hemodialysis patient, it's highest on Monday pre-dialysis (~90). It's lowest on Friday post-dialysis.

Shooting for BUN Targets

In the 1970s and early 1980s, a common practice was to prescribe hemodialysis therapy in order to attain a target BUN. Some doctors wanted the pre-treatment BUN never to exceed 80 mg/dl. Some thought that the urea level should be averaged over the course of the week and they used a Time Averaged Concentration (TAC) BUN value as a target. To try and hit these target BUNs, they adjusted the amount of time on dialysis, the blood flow rates, changed dialyzers, and issued restrictions on dietary protein. Using target BUNs seemed like a logical approach to prescribing hemodialysis. However, there were many patients who hitting these BUN targets and were still not doing well, and some displayed symptoms of being underdialyzed.

Questions No One Could Answer

It also became apparent that some patients who ate a lot of protein were healthier than other patients who strictly limited their protein intake. Why was this?  Why did patients who weighed the same and ate the same amount of protein require different amounts of dialysis therapy to stay healthy? Why were some patients who had pre-treatment BUNs of 100 perfectly healthy, yet others who had pre-treatment BUNs of 60 unhealthy and in need of more dialysis?

Doctors began searching for a better "marker" in the blood that could be used to predict patient outcomes. Since urea is a small molecule, some began looking at larger "middle molecules", thinking that these would offer a better indication of an overall "toxic effect" on the body. Some clinics tried dialyzing all the patients the same amount of time, such as four hours or more. Some doctors experimented with calculations for prescribing hemodialysis therapy that included the patient's weight and the dialyzer surface area. Unfortunately, in using all these methods, there were some patients who were hitting cautiously-set targets and were still displaying symptoms of being underdialyzed.

National Cooperative Dialysis Study (NCDS)

In the 1970's, the NCDS was funded to try to determine which dialysis therapies provided the best patient outcomes. Data from hundreds of patients was collected and this provided a huge database of information about dialysis patients for the first time. The NCDS study compared the different methods of measuring dialysis adequacy in use at that time, but it could not provide a definitive answer as to what was best.  However, the accumulated data did produce a later breakthrough. Two researchers, Dr. Frank Gotch and John Sargent (PhD), analyzed the study's database trying to find new common factors for those patients that were doing well (and for those patients that were doing poorly).

Using Urea Clearances

Using the data from the National Cooperative Dialysis Study, Gotch and Sargent separated the patients into two groups based on their symptoms those that were well and appeared adequately dialyzed and those that had complications and appeared underdialyzed. They found the data didn't make much sense until they invented a new way of measuring dialysis therapy. Their new method still utilized urea, but it didn't use a target BUN. Instead, it measured the volume of blood that was cleared of urea during a treatment and compared it to the amount of water in the patient's body. The end result was that Gotch and Sargent arrived at a simple, elegant formula for measuring dialysis therapy:

Kt / V        (pronounced: Kay Tee over Vee)

(The "K" stands for "clearance" of urea in milliliters per minute, "t" for "time" in minutes, and "V" for body water "volume" in liters. The calculation uses each patient's individual body water volume, so the value is "normalized". Patients who weigh the same amount can have vastly different body water volumes.)

The Questions are Finally Answered

Why were some patients who had urea levels of 100 perfectly healthy, yet others who had levels of 60 unhealthy and in need of more dialysis? Why did two patients who weighed the same amount need different lengths of dialysis treatments to stay healthy? The formula Kt/V effectively answered these questions for the first time. When Gotch and Sargent applied the Kt/V formula to the data they had for these patients, the healthy and unhealthy patients fell into two distinct numerical groupings. If the patient had a Kt/V value that was 1.0 or higher, they were doing well in terms of being adequately dialyzed. If they had a Kt/V value less than 0.8, they were underdialyzed and were doing poorly.

Urea Kinetic Modeling

This new approach became known as urea kinetic modeling. It uses Kt/V values to prescribe and measure dialysis therapy. It uses the results of two blood tests, pre and post treatment BUNs, in its calculations. Urea kinetic modeling includes protein metabolism analyses and provides care givers, as part of the Kt/V calculations, with the amount of protein that the patients are actually eating (It calculates the PCR - protein catabolic rate. Diet diaries are notoriously inaccurate). Another benefit of Gotch and Sargent's analyses was that it provided strong scientific evidence that dialysis patients were better off eating more protein, not less. As more data accumulated, it became apparent that reducing protein in the diet to keep the urea levels low was actually resulting in patients not getting enough protein to stay healthy (low albumin levels). Over the years, it also became apparent that there were additional long-term benefits for the patients in increasing their Kt/V values to 1.2 and higher.

Those defiant 1970's patients who ate more than their allotted amount of protein, and then were "punished" with more dialysis time, were actually in sync with today's best clinical practices.

Urea kinetic modeling requires inputting several treatment and patient variables and the use of complex mathematics. Due to this complexity, a programmable scientific calculator or a computer is required to perform the calculations. Around 1990, researchers were able to show a high degree of correlation between Kt/V values and urea reduction ratios (URR).  A URR can be calculated with simple algebra and only uses the same two blood tests as the Kt/V equations. While a URR is not as accurate as a Kt/V value, nor does it provide any information about the patient's protein intake, a URR value does provide an easy-to-calculate marker for dialysis adequacy. As an example, a Kt/V of 1.2 is roughly equivalent to a URR of about 63 percent. Like Kt/V, the higher the URR value, the better.

Here is a comparison of URR and Kt/V from the NIDDK web site.

A Word of Warning: Current medical literature suggests that persons with renal disease who still have some remaining renal function should limit their protein intake to preserve that remaining renal function. Dialysis patients generally have no remaining renal function. Please consult with your nephrologist and renal dietitian about the protein intake level that is most beneficial for you and your current condition.

Gary Peterson, February 2000

(Author's note: This quasi-history lesson is intended to introduce new dialysis personnel to the concepts of urea kinetic modeling and adequacy in a somewhat entertaining fashion (a la James Burke). This short summary is not comprehensive nor does it do justice to all of the work that was done on this topic over the years by so many individuals. Those interested in more thorough and complete accounts should consult the appropriate scientific journals.)

Warning:  Changes should never be made in a patient's treatment or care based solely on the information found here.  Every patient has unique healthcare concerns and considerations and all these factors must all be taken into account before any changes can be safely made.  All medical and therapeutic decisions must come from a qualified health care provider.  Read RenalWEB's Legal Disclaimer before proceeding.


  NEWS & LATEST ARTICLES
blue ball

Survival and Time-to-Transplantation of Peritoneal Dialysis Versus Hemodialysis for End-Stage Renal Disease Patients: Competing-Risks Regression Model in a Single Italian Center Experience - Free, Full-Text Article from Journal of Nephrology. - June 2017

blue ball

Free, Full-Text Articles from American Journal Of Kidney Diseases - June 2017

blue ball

New Magnet Technology Creates Easy Blood Access for Hemodialysis Patients - Press release from University Health Network (Toronto). Article in Press abstract from American Journal of Kidney Diseases. - June 14, 2017

blue ball

Ultrapure Versus Standard Dialysate: a Cost-Benefit Analysis - Early View Abstract from Seminars In Dialysis. - June 13, 2017

blue ball

Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival - Free, Full-Text, Issue-In-Progress Article from Kidney & Blood Pressure Research. - June 7, 2017

blue ball

Interplay of Volume, Blood Pressure, Organ Ischemia, Residual Renal Function, and Diet: Certainties and Uncertainties with Dialytic Management - Early View Abstract from Seminars In Dialysis. - June 5, 2017

blue ball

Baxter Touts HDx Theranova Data for ‘Extended’ Hemodialysis - Article from MASSDEVICE. - June 5, 2017

blue ball

Citrate Versus Heparin Anticoagulation in Continuous Renal Replacement Therapy in Small Children - Free, First Online, Open Access article from Pediatric Nephrology. - June 4, 2017

blue ball

Three-Stream, Bicarbonate-Based Hemodialysis Solution Delivery System Revisited: With an Emphasis on Some Aspects of Acid-Base Principles - Free, full-text article from Artificial Organs. - June 2, 2017

Editor's note: Make sure your clinic's medical director reads this article.

blue ball

Target Weight Achievement and Ultrafiltration Rate Thresholds: Potential Patient Implications - Free, Open Access Article from BMC Nephrology. - June 2, 2017

blue ball

High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration -Issue-in-Progress abstract from Blood Purification. - June 2, 2017

blue ball

Factors Associated With Functional Capacity in Hemodialysis Patients - Early View abstract from Artificial Organs. - June 1, 2017

blue ball

Continuous Renal Replacement Therapy: Forty-Year Anniversary - Free, full-text, Advance Online article from the International Journal of Artificial Organs. - May 31, 2017

blue ball

Treatment Adherence and Perception in Patients on Maintenance Hemodialysis: a Cross-Sectional Study from Palestine - Free, Open Access Article from BMC Nephrology. - May 30, 2017

blue ball

Obstacles to Reducing Plasma Levels of Uremic Solutes by Hemodialysis - Early View abstract from Seminars In Dialysis. - May 30, 2017

blue ball

Higher Ultrafiltration Rate Is Associated with Longer Dialysis Recovery Time in Patients Undergoing Conventional Hemodialysis - Issue-in-Progress abstract from American Journal of Nephrology. - May 30, 2017

blue ball

Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis - Issue-in-Progress abstract from Blood Purification. - May 30, 2017

blue ball

Prospective, Randomized, Multicenter, Controlled Trial (TRIATHRON 1) on a New Antithrombogenic Hydrophilic Dialysis Membrane - Advance Online abstract from the International Journal of Artificial Organs. - May 29, 2017

blue ball

A New Approach Combining Venoarterial Extracorporeal Membrane Oxygenation and CRRT for Adults: a Retrospective Study - Advance Online abstract from the International Journal of Artificial Organs. - May 28, 2017

blue ball

Medium Cutoff Membranes — Closer to the Natural Kidney Removal Function - Free, full-text, Advance Online article from the International Journal of Artificial Organs. - May 26, 2017

blue ball

Early View Abstracts from Artificial Organs - May 26, 2017

blue ball

FDA Recall Notice: MesaLabs Conductivity Standard Solution, 14 mS/cm, 32 ounces (950 ml) - Mesa Laboratories is recalling Conductivity/TDS Calibrator Solution due to failure to meet product specifications. These solutions are used remotely from the hemodialysis machine or water purification equipment, and do not come into contact with the patient. - May 24, 2017

blue ball

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and Practice Patterns Study - Article in Press abstract from American Journal of Kidney Diseases. - May 24, 2017

blue ball

Free, Open Access Articles from BMC Nephrology - May 22, 2017

blue ball

Insomnia, Muscular Cramps and Pruritus Have Low Intensity in Hemodialysis Patients with Good Dialysis Efficiency, Low Inflammation and Arteriovenous Fistula - First Online abstract from International Urology and Nephrology. - May 22, 2017

blue ball

Early Hospital Readmission among Hemodialysis Patients in the United States Is Associated with Subsequent Mortality - Article in Press abstract from Kidney International. - May 20, 2017

blue ball

Polymorphisms of T Helper Cell Cytokine-Associated Genes and Survival of Hemodialysis Patients - a Prospective Study - Free, Open Access Article from BMC Nephrology. - May 19, 2017

blue ball

Targeted Deprescribing in Patients on Hemodialysis to Reduce Polypharmacy - 29-minute YouTube video from Toronto General. - May 15, 2017

blue ball

The Rise of Expanded Hemodialysis - Free, full-text, Issue-in-Progress editorial from Blood Purification. - May 10, 2017

"The last evolution in the field of membranes is the development of a new class defined as “high retention onset” (HRO) due to the peculiar high sieving value in the middle to high molecular weight range. The introduction of HRO membranes in the clinical routine has enabled the development of a new concept therapy called “expanded hemodialysis".”

"This new therapy is likely to modify the outcome of end-stage kidney disease patients, thanks to the enhanced removal of molecules traditionally retained by current dialysis techniques."

Top of Page


  WEB RESOURCES
blue ball Latest Scientific Journal Articles on Hemodialysis Adequacy
blue ball Fact Sheets from ANNA: Hemodialysis and Pediatric ESRD: Hemodialysis (pdf format requires Adobe Acrobat reader)
Continuous Dialysis Therapies: Core Curriculum 2016 from the American Journal of Kidney Diseases
Body Weight, Body Water - (pdf format requires Adobe Acrobat reader) from Hemodialysis, Inc.
Dialysis Dose - (pdf format requires Adobe Acrobat reader) from Hemodialysis, Inc.
Dialysis Facility Compare - Feature from the Center for Medicare and Medicaid Services (CMS) that compare adequacy, anemia, and survival data of Medicare beneficiaries on hemodialysis at US dialysis facilities.
Getting Adequate Dialysis - from the Kidney School™ web site
For Manufacturers and CDRH Reviewers - Guidance for the Content of Premarket Notifications for Conventional and High Permeability Hemodialyzers from the Food and Drug Administration Center for Medical Devices web site
blue ball Hemodialysis - this is a growing library of key high-impact articles in nephrology, chosen by UKidney's contributors as suggested reading for nephrology trainees and practitioners.
blue ball HD Advanced Renal Educational Program - from Fresenius Medical Care (FMC)
Hemodiafiltration by Claudio Ronco (Editor), Bernard Canaud (Editor), Pedro Alijama (Editor) hardcover from Amazon.com
Hemodialysis 1947-2007: Six decades of achievements and challenges - (pdf) editorial from The International Journal of Artificial Organs - December 2007
Hemodialysis Administration: Strategies to Ensure Safe Patient Care - From the Sept. 2010 report from the PA Patient Safety Authority. - September 2010
blue ball

Intensive Hemodialysis: Potential for Improving Patient Outcomes - Free, Full-Text, Supplement Issue of American Journal of Kidney Diseases - November 2016
Articles include:

Just the Facts: Getting Enough Hemodialysis and Información esencial: Tener una hemodiálisis adecuada (pdf format requires Adobe Acrobat Reader) from the Life Options web site
United States Renal Data System (USRDS) Annual Data Report
Top of Page


  ESSENTIALS AND CLASSICS
Clinical Practice Guideline on Adequacy of Hemodialysis - a book available from the Renal Physicians Association web site
Hemodialysis Adequacy quality improvement from The Renal Network (ESRD Network 9/10) web page
Hemodialysis Dose and Adequacy from NIDDK web site
National Kidney Foundation's (NKF) Kidney Disease Outcomes Quality Initiative (K/DOQI™)
blue ball Hemodialysis: Core Curriculum 2014 - Free, full-text article from the American Journal of Kidney Diseases - January 2014
European Best Practice Guidelines for Haemodialysis (Part 1) and European Best Practice Guideline for Haemodialysis Part 2 - guidelines endorsed by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)
The "V" in Kt/V - a tutorial from RenalWEB
Top of Page


  DAILY HOME HEMODIALYSIS
Daily, Home & Nocturnal Hemodialysis Topic Page from RenalWEB
Latest Scientific Journal Articles on Home and Daily Dialysis
Home Dialysis Central web site
Find a home dialysis center in your area from the Home Dialysis Central web site
Rogosin Kidney Center of The Rogosin Institute is the first center in the New York City metropolitan area to offer patients nocturnal hemodialysis. This type of self care home dialysis offers patients independence and freedom for day time activities.
Top of Page


  PUBMED SEARCHES (National Library of Medicine's MEDLINE Database)
adequacy and hemodialysis Continually Updated!
kinetics and hemodialysis Continually Updated!
urea kinetic and Gotch Continually Updated!
URR and hemodialysis Continually Updated!
home hemodialysis Continually Updated!
MEDLINE / Pubmed Information from the National Library of Medicine
Top of Page


  K/DOQI™ -  Kidney Disease Outcomes Quality Initiative

Clinical Practice Guidelines for Hemodialysis Adequacy 2015 Updates

I: Clinical Practice Guidelines for Hemodialysis Adequacy

Guideline 1. Timing of Hemodialysis Initiation
Guideline 2. Frequent and Long Duration Hemodialysis
Guideline 3. Measurement of Dialysis---Urea Kinetics
Guideline 4. Volume and Blood Pressure Control---Treatment Time And Ultrafiltration Rate
Guideline 5. Hemodialysis Membranes

 
K/DOQI Home Page from the National Kidney Foundation web site
Top of Page


  DISCUSSION FORUM
General Dialysis Nursing Issues and Questions - RenalWEB Discussion Forum
Blood Volume Monitoring / Fluid Management - RenalWEB Discussion Forum
Top of Page


  PRODUCTS
 
Top of Page


  INPUT / SUGGESTIONS
E-mail to RenalWEB on the Hemodialysis Adequacy Topic
Top of Page

Click for the Membrana web site

 

Except where noted, no information within the RenalWEB web site can be copied, duplicated, or reproduced in any form without the express written consent of RenalWEB.